MedTrace Logo

Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis

NCT00333164 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-12-19

No results posted yet for this study

Summary

Multi-center, open-labelled randomized controlled trial, to study the effect of aspirin plus cilostazol and aspirin alone on the progression of intracranial arterial stenosis, in 200 chronic stroke patients with 50-99% stenosis, to be followed up for 2 years

Conditions

  • Cerebrovascular Disease

Interventions

DRUG

Asprin, Cilostazol

Sponsors & Collaborators

  • Foundation for Biomedical Research and Innovation

    collaborator OTHER

  • Neurology, Tokyo Women's Medical University, School of Medicine

    collaborator OTHER

  • Kobe City General Hospital

    collaborator OTHER

  • Tohoku University

    collaborator OTHER

  • Kyushu University

    collaborator OTHER

  • Department of Neurology, Saiseikai Central Hospital

    collaborator UNKNOWN

  • China National Center for Cardiovascular Diseases

    collaborator OTHER_GOV

  • Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

    lead OTHER

Principal Investigators

  • Shinichiro Uchiyama, M.D. PhD · Department of Neurology, Tokyo Women's Medical University School of Medicine

  • Nobuyuki Sakai, M.D. PhD · Kobe City General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2012-03-31
Completion
2012-03-31

Countries

  • Japan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00333164 on ClinicalTrials.gov